Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2026-03-11 @ 11:31 AM
Study NCT ID:
NCT03231969
Status:
COMPLETED
Last Update Posted:
2023-03-16
First Post:
2017-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model
Sponsor:
Faes Farma, S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-20
First Submit QC Date:
None
Study First Post Date:
2017-07-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-09
Results First Submit QC Date:
None
Results First Post Date:
2021-11-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-11-24
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-03-15
Last Update Post Date:
2023-03-16
Last Update Post Date Type:
ACTUAL